MILESTONE PHARMACEUTICALS IN (MIST) Stock Income Statement
NASDAQ:MIST - Nasdaq - CA59935V1076 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 1.00M | 5.00M | 15.00M | |||
| Operating Expenses | 52.15M | 42.10M | 62.10M | 64.64M | 58.07M | |||
| Research and Development | 15.89M | 14.62M | 30.96M | 39.74M | 38.67M | |||
| Selling, General, and Administrative Expenses | 36.45M | 27.75M | 31.05M | 24.81M | 19.40M | |||
| Operating Income | -52.15M | -42.10M | -61.10M | -59.64M | -43.07M | |||
| Interest Income/Expense | 223.00K | 583.00K | 1.41M | 1.25M | 220.00K | |||
| Income Before Taxes | -51.93M | -41.52M | -59.69M | -58.39M | -42.85M | |||
| Income Tax | N/A | N/A | N/A | N/A | 0.00 | |||
| Net Income | -51.93M | -41.52M | -59.69M | -58.39M | -42.85M | |||
| EBITDA | -52.05M | -42.00M | -61.01M | -59.55M | -42.98M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.86 | -0.67 | -1.39 | -1.38 | -1.02 | |||
| Non GAAP EPS | -0.79 | -0.69 | -1.39 | -1.37 | -1.02 | |||
| Statistics | ||||||||
| Profit Margin | N/A | N/A | -5968.50% | -1167.80% | -285.67% | |||
| Operating Profit Margin | N/A | N/A | -6109.80% | -1192.80% | -287.13% | |||
All data in USD